On October 1, Caris Life Sciences, Inc. fell 5.06% in regular trading, trading at $29.09 USD/share, with Turnover of $37.6489 million.

Within the Biotechnology sector where Caris Life Sciences, Inc. belongs, individual stock performance was mixed. Among individual stocks, Moderna down 0.43%, United Therapeutics up 6.42%, Regeneron Pharmaceuticals down 3.50%, Amgen down 2.70%, Natera up 0.58%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)